Hypertensive Patient Serum Uric Acid and Cardiorenal Outcomes Before and After COVID-19

A retrospective cross-sectional study from Pu’er City Hospital of Traditional Chinese Medicine compared 3,036 hypertensive adults across two periods: pre-pandemic (January 2017–December 2019) and post-pandemic (January 2023–March 2025). The dataset, authored by Jin Yuan and shared under a CC-BY-4.0 license, includes serum uric acid levels and cardiorenal complication prevalence to assess pandemic-related changes and interaction effects.

Use Cases

• Assess changes in serum uric acid levels based on the pre- and post-pandemic periods described.
• Investigate the association between hyperuricemia and cardiorenal complication risk in hypertensive patients.
• Model multiplicative and additive interaction effects between the study period and hyperuricemia status.
• Conduct subgroup analyses on cardiorenal outcomes across age and sex groups as mentioned in the results.

Strengths

• Includes 3,036 patient records, with 1,482 from the pre-pandemic period and 1,554 from the post-pandemic period.
• Study design explicitly compares two non-overlapping time periods, allowing for temporal analysis.
• Results include specific statistical measures (ORs, CIs, RERI, AP, S) for interaction effects.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.
• Data is from a single hospital, which may reflect geographic or institutional bias.

Provenance

Source

Pu’er City Hospital of Traditional Chinese Medicine

Collection Method

Retrospective cross-sectional study of hospital records.

Time Range

Pre-pandemic: January 2017–December 2019; Post-pandemic: January 2023–March 2025

Freshness

Last updated 2026-05-21 04:38:46; freshness should be verified.

Geography

Pu’er City, China